Clinical-pathological correlation of KRAS mutation status in metastatic colorectal adenocarcinoma (2013)
- Authors:
- Ribeiro, Karen Bento
- Ribeiro, Karoline Bento
- Feres, Omar
- Rocha, José Joaquim Ribeiro da
- Rapatoni, Liane
- Garcia, Sérgio Britto
- Silva, Alfredo Ribeiro da
- Perdoná, Gleici da Silva Castro
- Souza, Hayala C. C. de
- Santillan, Saul Isaac Garrido
- Oliveira, Harley Francisco de
- Tirapelli, Daniela Pretti da Cunha
- Peria, Fernanda Maris
- USP affiliated authors: FERES, OMAR - FMRP ; ROCHA, JOSE JOAQUIM RIBEIRO DA - FMRP ; GARCIA, SERGIO BRITTO - FMRP ; SILVA, ALFREDO RIBEIRO DA - FMRP ; PERDONÁ, GLEICI DA SILVA CASTRO - FMRP ; OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; TIRAPELLI, DANIELA PRETTI DA CUNHA - FMRP ; PERIA, FERNANDA MARIS - FMRP
- Unidade: FMRP
- DOI: 10.4021/wjon719w
- Subjects: NEOPLASIAS; ONCOLOGIA; ADENOCARCINOMA
- Language: Inglês
- Imprenta:
- Source:
- Título: World Journal of Oncology
- ISSN: 1920-4531
- Volume/Número/Paginação/Ano: v. 4, n. 4-5, p. 179-187, 2013
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc
-
ABNT
RIBEIRO, Karen Bento et al. Clinical-pathological correlation of KRAS mutation status in metastatic colorectal adenocarcinoma. World Journal of Oncology, v. 4, n. 4-5, p. 179-187, 2013Tradução . . Disponível em: https://doi.org/10.4021/wjon719w. Acesso em: 10 nov. 2024. -
APA
Ribeiro, K. B., Ribeiro, K. B., Feres, O., Rocha, J. J. R. da, Rapatoni, L., Garcia, S. B., et al. (2013). Clinical-pathological correlation of KRAS mutation status in metastatic colorectal adenocarcinoma. World Journal of Oncology, 4( 4-5), 179-187. doi:10.4021/wjon719w -
NLM
Ribeiro KB, Ribeiro KB, Feres O, Rocha JJR da, Rapatoni L, Garcia SB, Silva AR da, Perdoná G da SC, Souza HCC de, Santillan SIG, Oliveira HF de, Tirapelli DP da C, Peria FM. Clinical-pathological correlation of KRAS mutation status in metastatic colorectal adenocarcinoma [Internet]. World Journal of Oncology. 2013 ; 4( 4-5): 179-187.[citado 2024 nov. 10 ] Available from: https://doi.org/10.4021/wjon719w -
Vancouver
Ribeiro KB, Ribeiro KB, Feres O, Rocha JJR da, Rapatoni L, Garcia SB, Silva AR da, Perdoná G da SC, Souza HCC de, Santillan SIG, Oliveira HF de, Tirapelli DP da C, Peria FM. Clinical-pathological correlation of KRAS mutation status in metastatic colorectal adenocarcinoma [Internet]. World Journal of Oncology. 2013 ; 4( 4-5): 179-187.[citado 2024 nov. 10 ] Available from: https://doi.org/10.4021/wjon719w - Fatigue in patients with colorectal cancer treated with capecitabine and oxaliplatin
- KRAS mutation associated with CD44/CD166 immuoexpression as predictors of worse outcome in metastic colon cancer
- CHK2 immunohistochemical expression in colon cancer and its relation with clinicopathological features and outcome in metastatic colon cancer patients
- Comparative evaluation of oncologic outcomes in colon cancer
- Analysis of gene expression EGFR and KRAS, microRNA-21 and microRNA-203 in patients with colon and rectal cancer and correlation with clinical outcome and prognostic factors
- Transanal endoscopic operation for rectal cancer after neoadjuvant therapy
- Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer
- CHK2 expression as predictor factor of tumor aggressiveness and shorter survival in metastatic colon cancer patients
- Toxicidade aguda no tratamento neoadjuvante de neoplasia de reto utilizando radioterapia e capecitabina
- Hyperbaric oxygen therapy reduces COX-2 expression in a dimethylhydrazine-induced rat model of colorectal carcinogenesis
Informações sobre o DOI: 10.4021/wjon719w (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
